Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Depreciation Expense (2016 - 2019)

Xtant Medical Holdings (XTNT) has disclosed Depreciation Expense for 9 consecutive years, with $800000.0 as the latest value for Q3 2019.

  • On a quarterly basis, Depreciation Expense changed 0.0% to $800000.0 in Q3 2019 year-over-year; TTM through Sep 2019 was $3.1 million, a 34.78% increase, with the full-year FY2018 number at $3.2 million, down 15.79% from a year prior.
  • Depreciation Expense was $800000.0 for Q3 2019 at Xtant Medical Holdings, up from $700000.0 in the prior quarter.
  • In the past five years, Depreciation Expense ranged from a high of $2.0 million in Q3 2017 to a low of -$100000.0 in Q4 2017.
  • A 5-year average of $653061.0 and a median of $747850.0 in 2016 define the central range for Depreciation Expense.
  • Peak YoY movement for Depreciation Expense: plummeted 139.99% in 2017, then skyrocketed 900.0% in 2018.
  • Xtant Medical Holdings' Depreciation Expense stood at $112750.0 in 2015, then soared by 121.8% to $250078.0 in 2016, then tumbled by 139.99% to -$100000.0 in 2017, then surged by 900.0% to $800000.0 in 2018, then changed by 0.0% to $800000.0 in 2019.
  • Per Business Quant, the three most recent readings for XTNT's Depreciation Expense are $800000.0 (Q3 2019), $700000.0 (Q2 2019), and $800000.0 (Q1 2019).